Imaging scans to guide esophageal cancer treatment before surgery
Part of Cancer, Digestive system clinical trials.
This study looks at whether CT and MRI scans taken before and after chemotherapy or radiation can help doctors predict how well the treatment is working and what the cancer looks like after surgery. It may help improve treatment plans for people with esophageal cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with esophageal cancer.
- You received chemotherapy, radiation, or immunotherapy before your surgery.
- You had CT and MRI scans before and after this pre-surgery treatment.
- Your medical records include your test results and surgical pathology details.
- You have not had other cancers or previous cancer treatments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses special scans (spectral CT, multimodal MRI, and FAPI PET-CT) before and after treatment to better detect if esophageal cancer has spread to lymph nodes. It aims to improve diagnosis by comparing scan images with tissue removed during surgery.
This trial is testing a new treatment approach for esophageal cancer that includes chemotherapy and immunotherapy before surgery. The goal is to see if this combination can help shrink the tumor and improve outcomes.
This study tests whether special PET/CT scans can help predict how well immunotherapy works before surgery for esophageal cancer. It aims to improve treatment planning by identifying patients who may need additional therapy.
This Phase 1 study uses specialized imaging (including MRI) to better “see” low-oxygen areas in esophageal cancer and help guide individualized radiation treatment. It aims to improve how radiation is planned and delivered while checking safety.
This trial uses a special MRI technique to see if it can predict how well esophageal cancer responds to chemo-radiotherapy before surgery. It may help doctors choose the best treatment plan for you.
This trial uses artificial intelligence (AI) to help plan personalized treatment for esophageal cancer by combining images and tissue samples. It aims to improve care by guiding doctors to choose the best therapy for each person.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.